Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia

Great effort is spent on developing therapies to improve the dire outcomes of those diagnosed with acute myeloid leukemia. The methods for quantifying response to therapeutic intervention have however lacked sensitivity. Patients achieving a complete remission as defined by conventional cytomorpholo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dillon, Laura W., Hayati, Sheida, Roloff, Gregory W., Tunc, Ilker, Pirooznia, Mehdi, Mitrofanova, Antonina, Hourigan, Christopher S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355494/
https://www.ncbi.nlm.nih.gov/pubmed/30171026
http://dx.doi.org/10.3324/haematol.2018.203133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355494/
https://www.ncbi.nlm.nih.gov/pubmed/30171026
http://dx.doi.org/10.3324/haematol.2018.203133

Ejemplares similares